Lululemon shares dive as challenges keep investors at bay ahead of new CEO’s tenure
Lululemon Athletica's shares fell 18% premarket Friday after cutting its full-year forecast for the second time. The company faces margin shrinkage, brand perception issues, and competition. Incoming CEO Heidi O'Neill, starting September 8, must address merchandising missteps and declining North American sales. Analysts lowered price targets, with Piper Sandler setting the lowest at $80. Shares trade at 11.50x forward earnings, below peers Nike and Adidas.
How this was made

The 30-second read
Why it matters
The guidance downgrade triggers a sharp sell‑off, with analysts revising price targets lower and investors reassessing growth outlook.
Market read
The news is a primary disclosure of a material guidance cut, causing a significant price move and prompting immediate trading decisions.
What to watch
Recent inventory reductions and upcoming product launches could mitigate the revenue decline if executed effectively.
Background
Lululemon announced a second full‑year forecast cut ahead of the new CEO's start date, highlighting margin compression and market‑share loss.
Ticker impact
Lululemon cut its full‑year forecast for the second time, sending the stock down ~18% pre‑market and wiping out over $2.5 bn in market value.
Expect continued intraday decline toward $80‑$85 target as analysts lower expectations.
Guidance cuts historically trigger sharp sell‑offs; the 18% move and $2.5 bn loss underscore material impact.
Market effects
Athletic apparel sector faces heightened scrutiny; peers Nike and Adidas may see relative strength as investors rotate.
U.S. consumer discretionary sentiment weakens, potentially pressuring related retail stocks.
Lululemon's slowdown adds to broader concerns about post‑pandemic consumer spending trends.
Counterpoint
If the new CEO can quickly execute cost cuts and revitalize the brand, the stock may be oversold and present a buying opportunity.
Key entities
- ExecutiveHeidi O’Neill
Incoming CEO slated to start September 8.
- AnalystMorgan Stanley
Warned of further sales deterioration in the second half.



